• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从血流感染中分离出的产奥沙西林酶β-内酰胺酶(OXA-48)和新德里金属β-内酰胺酶(NDM-1)的耐碳青霉烯类肺炎克雷伯菌菌株的转归

Outcomes in Oxacillinases β-Lactamases (OXA-48) and New Delhi Metallo-β-Lactamase (NDM-1)-Producing, Carbapenem-Resistant Klebsiella Pneumoniae Isolates Obtained From Bloodstream Infections.

作者信息

Verma Anuragani, Jain Parul, Tripathi Piyush, Kalyan Raj K, Verma Sheetal, Venkatesh Vimala

机构信息

Microbiology, King George's Medical University, Lucknow, IND.

Clinical Microbiology, King George's Medical University, Lucknow, IND.

出版信息

Cureus. 2022 Jul 24;14(7):e27197. doi: 10.7759/cureus.27197. eCollection 2022 Jul.

DOI:10.7759/cureus.27197
PMID:36039200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9395761/
Abstract

BACKGROUND

Carbapenemase-producing (CRKP) has become a menace in several intensive care units, which needs to be controlled immediately after being reported by a laboratory. Detection in the laboratory is usually done using phenotypic methods and it is not known whether knowledge of these genes helps in individual patient management. This study aimed to compare the outcomes of oxacillinases β-lactamases (OXA-48) and New Delhi metallo-β-lactamase (NDM-1)-producing CRKP isolates, the two most common carbapenemases reported from India, obtained from patients with bloodstream infections in an ICU in a tertiary care center in North India and to compare the different laboratory methods for their detection.

MATERIALS AND METHODS

isolates obtained from the blood culture of patients admitted to various ICUs were subjected to conventional polymerase chain reaction (PCRs) for blaNDM and blaOXA48-like genes. Those positive for any of the genes were tested by the modified carbapenem inactivation method (mCIM) and if found positive were also subjected to ethylenediamine tetraacetic acid (EDTA)-modified carbapenem inactivation method (eCIM). Antibiotic susceptibility tests (AST) were performed and clinical data were recorded.

RESULTS

A total of 49 isolates were positive for one or more carbapenemase genes (30 {61.2%} for blaNDM gene only, 13 {26.5%)} for blaOXA48-like gene only, and six {12.2%} for both). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of mCIM were found to be 77.6%, 100%, 100%, and 78.9%, respectively. Statistically significant differences were found in the AST pattern between the isolates with two genes. Increased MIC levels of colistin were observed, though they lay in the sensitive range. Mortality occurred in all six patients who were infected with CRKP harboring both the genes though no significant difference was observed in NDM and OXA-48 producing CRKP isolates.

CONCLUSION

Surveillance of carbapenemase genes in a hospital setting is essential. The possible reasons for the low diagnostic accuracy of mCIM and differences in AST patterns are discussed.

摘要

背景

产碳青霉烯酶肺炎克雷伯菌(CRKP)已成为多个重症监护病房的一大威胁,实验室报告后需立即加以控制。实验室检测通常采用表型方法,而这些基因的相关知识是否有助于个体患者的管理尚不清楚。本研究旨在比较产氧碳青霉烯酶β-内酰胺酶(OXA-48)和新德里金属β-内酰胺酶(NDM-1)的CRKP分离株的转归,这两种是印度报告的最常见的碳青霉烯酶,它们来自印度北部一家三级护理中心重症监护病房的血流感染患者,并比较检测它们的不同实验室方法。

材料与方法

从入住各个重症监护病房患者的血培养中获得的分离株,针对blaNDM和blaOXA48样基因进行常规聚合酶链反应(PCR)。对任何一个基因呈阳性的分离株采用改良碳青霉烯灭活法(mCIM)进行检测,若结果为阳性,则进一步采用乙二胺四乙酸(EDTA)改良碳青霉烯灭活法(eCIM)检测。进行抗生素敏感性试验(AST)并记录临床数据。

结果

共有49株分离株一种或多种碳青霉烯酶基因呈阳性(仅blaNDM基因阳性30株{61.2%},仅blaOXA48样基因阳性13株{26.5%},两种基因均阳性6株{12.2%})。发现mCIM的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为77.6%、100%、100%和78.9%。在具有两种基因的分离株之间,AST模式存在统计学显著差异。虽然黏菌素的最低抑菌浓度(MIC)水平仍在敏感范围内,但有所升高。感染同时携带这两种基因的CRKP的所有6例患者均死亡,不过在产NDM和产OXA-48的CRKP分离株之间未观察到显著差异。

结论

在医院环境中监测碳青霉烯酶基因至关重要。讨论了mCIM诊断准确性低和AST模式差异的可能原因。

相似文献

1
Outcomes in Oxacillinases β-Lactamases (OXA-48) and New Delhi Metallo-β-Lactamase (NDM-1)-Producing, Carbapenem-Resistant Klebsiella Pneumoniae Isolates Obtained From Bloodstream Infections.从血流感染中分离出的产奥沙西林酶β-内酰胺酶(OXA-48)和新德里金属β-内酰胺酶(NDM-1)的耐碳青霉烯类肺炎克雷伯菌菌株的转归
Cureus. 2022 Jul 24;14(7):e27197. doi: 10.7759/cureus.27197. eCollection 2022 Jul.
2
Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital.印度某医院新生儿重症监护病房中产新德里金属β-内酰胺酶 1 的耐碳青霉烯类新型序列型肺炎克雷伯菌的分子特征。
Int J Antimicrob Agents. 2019 Apr;53(4):525-529. doi: 10.1016/j.ijantimicag.2018.12.005. Epub 2018 Dec 20.
3
Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing .用于检测产金属β-内酰胺酶的乙二胺四乙酸(EDTA)修饰碳青霉烯灭活方法的评估
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.02015-19.
4
Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal.尼泊尔加德满都一家三级医疗中心耐碳青霉烯类肺炎克雷伯菌分离株中NDM-1和VIM基因的检测
Chemotherapy. 2021;66(5-6):199-209. doi: 10.1159/000518256. Epub 2021 Aug 31.
5
Evaluation of point mutation carbapenemase-producing in Prapokklao Hospital, Thailand.泰国普拉波克拉奥医院产碳青霉烯酶点突变情况的评估。
Microbiol Spectr. 2024 Oct 17;12(12):e0019824. doi: 10.1128/spectrum.00198-24.
6
High prevalence of OXA-48-like and NDM carbapenemases among carbapenem resistant of clinical origin from Iran.来自伊朗临床分离的耐碳青霉烯类细菌中,OXA-48样和NDM碳青霉烯酶的高流行率。
Iran J Microbiol. 2023 Oct;15(5):609-615. doi: 10.18502/ijm.v15i5.13866.
7
Reliability of carbapenem inactivation method (CIM) and modified carbapenem inactivation method (mCIM) for detection of OXA-48-like and NDM-1.用于检测OXA-48样酶和NDM-1的碳青霉烯灭活方法(CIM)及改良碳青霉烯灭活方法(mCIM)的可靠性
Indian J Med Microbiol. 2021 Oct-Dec;39(4):451-456. doi: 10.1016/j.ijmmb.2021.07.004. Epub 2021 Jul 28.
8
Antimicrobial Resistance Patterns, Sequence Types, Virulence and Carbapenemase Genes of Carbapenem-Resistant Clinical Isolates from a Tertiary Care Teaching Hospital in Zunyi, China.中国遵义一家三级甲等教学医院耐碳青霉烯类临床分离株的抗菌药物耐药模式、序列类型、毒力及碳青霉烯酶基因
Infect Drug Resist. 2023 Jan 29;16:637-649. doi: 10.2147/IDR.S398304. eCollection 2023.
9
Detection of various beta-Lactamases in and sp.: A study from Tertiary Care Centre of North India.检测和 中的各种β-内酰胺酶:来自印度北部三级护理中心的研究。
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):390-396. doi: 10.4103/ijmm.IJMM_20_253.
10
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.中国一家儿童医院耐碳青霉烯类肺炎克雷伯菌血流感染的流行病学:新德里金属β-内酰胺酶-1为主导
Microb Drug Resist. 2018 Mar;24(2):154-160. doi: 10.1089/mdr.2017.0031. Epub 2017 Jun 8.

本文引用的文献

1
High-Resolution Genomic Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates: A Multicentric Retrospective Indian Study.碳青霉烯类耐药肺炎克雷伯菌的高分辨率基因组分析:一项多中心回顾性印度研究。
Clin Infect Dis. 2021 Dec 1;73(Suppl_4):S300-S307. doi: 10.1093/cid/ciab767.
2
Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.从血流感染中分离出的耐碳青霉烯肺炎克雷伯菌:印度的经验。
Pathog Glob Health. 2017 Jul;111(5):240-246. doi: 10.1080/20477724.2017.1340128. Epub 2017 Jul 2.
3
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae.用于肠杆菌科细菌中碳青霉烯酶产生表型检测的改良碳青霉烯灭活方法
J Clin Microbiol. 2017 Aug;55(8):2321-2333. doi: 10.1128/JCM.00193-17. Epub 2017 Apr 5.
4
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌感染患者死亡率的系统评价与荟萃分析
Ann Clin Microbiol Antimicrob. 2017 Mar 29;16(1):18. doi: 10.1186/s12941-017-0191-3.
5
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.耐碳青霉烯类肺炎克雷伯菌的黏菌素耐药性:实验室检测及其对死亡率的影响
Clin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805.
6
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.产碳青霉烯酶肺炎克雷伯菌,一种注定在全球医院感染中占据主导地位的关键病原体。
Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84. doi: 10.1128/AAC.01019-15. Epub 2015 Jul 13.
7
Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae.产超广谱β-内酰胺酶肺炎克雷伯菌生物膜形成及其对抗菌药物(庆大霉素和黏菌素)敏感性的研究
J Antimicrob Chemother. 2014 Apr;69(4):1027-34. doi: 10.1093/jac/dkt487. Epub 2014 Jan 9.
8
Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae.肺炎克雷伯菌同时产生NDM-1和OXA-232。
Emerg Infect Dis. 2014 Jan;20(1):163-5. doi: 10.3201/eid2001.130904.
9
Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.产碳青霉烯酶肠杆菌科细菌:一项重大公共卫生挑战概述
Med Mal Infect. 2014 Feb;44(2):51-6. doi: 10.1016/j.medmal.2013.11.007. Epub 2013 Dec 18.
10
Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011.意大利产 KPC 碳青霉烯酶肺炎克雷伯菌的流行扩散:2011 年 5 月 15 日至 6 月 30 日首次全国调查结果。
Euro Surveill. 2013 May 30;18(22):20489.